Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
RedHill Biopharma (RDHL)
NASDAQ:RDHL
Holding RDHL?
Track your performance easily
RDHL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.43 - $82.00
Previous Close$10.34
Volume32.67K
Average Volume (3M)330.99K
Market Cap
$13.18M
Enterprise Value$8.78M
Total Cash (Recent Filing)$5.57M
Total Debt (Recent Filing)$1.17M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Mar 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-78.99
Shares Outstanding1,280,539
10 Day Avg. Volume53,564
30 Day Avg. Volume330,990
Standard Deviation0.53
R-Squared0.13
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)6.02
Price to Sales (P/S)2.03
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.24
Enterprise Value/Gross Profit2.86
Enterprise Value/Ebitda-1.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RedHill Biopharma News
PremiumCompany Announcements
RedHill Biopharma Shareholders Approve Key Resolutions
PremiumCompany Announcements
RedHill Biopharma Postpones Shareholder MeetingRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RDHL FAQ
What was RedHill Biopharma’s price range in the past 12 months?
RedHill Biopharma lowest stock price was $6.42 and its highest was $82.00 in the past 12 months.
What is RedHill Biopharma’s market cap?
Currently, no data Available
When is RedHill Biopharma’s upcoming earnings report date?
RedHill Biopharma’s upcoming earnings report date is Mar 13, 2025 which is in 174 days.
How were RedHill Biopharma’s earnings last quarter?
Currently, no data Available
Is RedHill Biopharma overvalued?
According to Wall Street analysts RedHill Biopharma’s price is currently Overvalued.
Does RedHill Biopharma pay dividends?
RedHill Biopharma does not currently pay dividends.
What is RedHill Biopharma’s EPS estimate?
RedHill Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RedHill Biopharma have?
RedHill Biopharma has 1,274,680 shares outstanding.
What happened to RedHill Biopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of RedHill Biopharma?
Among the largest hedge funds holding RedHill Biopharma’s share is ARK Investment Management LLC. It holds RedHill Biopharma’s shares valued at N/A.
---
RedHill Biopharma Stock Smart Score
Company Description
RedHill Biopharma
RedHill Biopharma Ltd. is a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary drugs for the treatment of gastrointestinal diseases. It operates through two segments: Commercial Operations and Research & Development. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's U.S. subsidiary. The Research and Development segment includes all activities related to the research and development of therapeutic candidates and is being performed by the Company. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
---
RDHL Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---